Overview
Mark Mihanovic and Richard Smith were members of a McDermott team that represented Massachusetts-based Corindus Vascular Robotics Inc. in setting IPO terms together with another venture capital-backed medical device maker. Corindus sells the only U.S. Food and Drug Administration-approved vascular robotic system for the placement of stents.
